Immunovia
Develops blood tests for early pancreatic cancer detection in high-risk individuals.
IMMNOV | ST
Overview
Corporate Details
- ISIN(s):
- SE0006091997 (+2 more)
- LEI:
- 549300KHWL6KK1XGUO81
- Country:
- Sweden
- Address:
- Scheelevägen 8, 223 63 LUND
- Website:
- https://immunovia.com/
- Sector:
- Human health and social work activities
- Industry:
- Other human health activities
Description
Immunovia is a diagnostics company dedicated to revolutionizing the early detection of pancreatic cancer to improve patient survival rates. The company's primary product is the PancreaSure™ test, a simple, blood-based assay designed to identify biomarkers associated with pancreatic cancer in its early, more treatable stages (1 and 2). The test is specifically targeted at individuals at high risk for the disease due to family history or genetic mutations, offering a convenient and accurate method for annual surveillance. By focusing on early detection, Immunovia addresses a critical unmet need in oncology, aiming to provide a diagnostic tool that can significantly enhance patient outcomes for one of the deadliest forms of cancer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-28 14:00 |
Declaration of Voting Results & Voting Rights Announcements
Ändring av antalet aktier och röster i Immunovia AB (publ)
|
Swedish | 48.3 KB | ||
| 2025-11-28 14:00 |
Declaration of Voting Results & Voting Rights Announcements
Change in number of shares and votes in Immunovia AB (publ)
|
English | 47.3 KB | ||
| 2025-11-26 08:30 |
Quarterly Report
|
Swedish | 2.5 MB | ||
| 2025-11-26 08:30 |
Quarterly Report
|
English | 2.4 MB | ||
| 2025-11-13 14:01 |
Major Shareholding Notification
|
Swedish | 10.6 KB | ||
| 2025-10-29 18:30 |
Share Issue/Capital Change
Immunovia genomför en riktad nyemission av aktier till garanter i samband med d…
|
Swedish | 70.3 KB | ||
| 2025-10-29 18:30 |
Share Issue/Capital Change
Immunovia carries out a directed issue of shares to guarantors in connection wi…
|
English | 72.5 KB | ||
| 2025-10-23 16:00 |
Share Issue/Capital Change
Immunovia offentliggör utfallet i företrädesemissionen
|
Swedish | 67.5 KB | ||
| 2025-10-23 16:00 |
Share Issue/Capital Change
Immunovia announces outcome of the rights issue
|
English | 68.7 KB | ||
| 2025-10-22 12:48 |
Major Shareholding Notification
|
Swedish | 10.6 KB | ||
| 2025-10-21 10:22 |
Major Shareholding Notification
|
Swedish | 10.6 KB | ||
| 2025-10-20 09:55 |
Major Shareholding Notification
|
Swedish | 10.6 KB | ||
| 2025-10-16 08:30 |
Share Issue/Capital Change
Sista dag för handel med teckningsrätter i Immunovias företrädesemission
|
Swedish | 67.7 KB | ||
| 2025-10-16 08:30 |
Share Issue/Capital Change
The last day of trading in subscription rights in Immunovia's rights issue
|
English | 69.7 KB | ||
| 2025-10-03 15:00 |
Share Issue/Capital Change
Immunovia publishes information document regarding rights issue
|
English | 69.2 KB |
Automate Your Workflow. Get a real-time feed of all Immunovia filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Immunovia
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Immunovia via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2020-03-24 | Hans Johansson | Other | Buy | 5,082 | 500,424.54 SEK |
Peer Companies
